Evaluation of madurahydroxylactone as a slow release antibacterial implant coating.
about
Drugs as matrix to detect their own drug delivery system of PEG-b-PCL block copolymers in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.Phosphate conversion coating reduces the degradation rate and suppresses side effects of metallic magnesium implants in an animal model.Susceptibility of metallic magnesium implants to bacterial biofilm infections.Alkalization is responsible for antibacterial effects of corroding magnesium.Controlled drug release from antibiotic-loaded layered double hydroxide coatings on porous titanium implants in a mouse model.A polymer-free Paclitaxel eluting coronary stent: effects of solvents, drug concentrations and coating methods.
P2860
Evaluation of madurahydroxylactone as a slow release antibacterial implant coating.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Evaluation of madurahydroxylactone as a slow release antibacterial implant coating.
@en
Evaluation of madurahydroxylactone as a slow release antibacterial implant coating.
@nl
type
label
Evaluation of madurahydroxylactone as a slow release antibacterial implant coating.
@en
Evaluation of madurahydroxylactone as a slow release antibacterial implant coating.
@nl
prefLabel
Evaluation of madurahydroxylactone as a slow release antibacterial implant coating.
@en
Evaluation of madurahydroxylactone as a slow release antibacterial implant coating.
@nl
P2093
P2860
P1476
Evaluation of madurahydroxylactone as a slow release antibacterial implant coating
@en
P2093
Hansjörg Hauser
Manfred Nimtz
Martin Stieve
Matthias Schnabelrauch
Meike Stiesch
Muhammad Badar
Peter P Mueller
Sebastian Vogt
Thomas Lenarz
P2860
P304
P356
10.2174/1874120701004010263
P577
2010-11-03T00:00:00Z